Bayer Schering Pharma SVP-Global Business Development And Licensing Michael Yeomans: An Interview With “The Pink Sheet” DAILY (Part 2 of 2)
This article was originally published in The Pink Sheet Daily
Executive Summary
Yeomans discusses how the firm’s increasing biologics capabilities fits into Bayer Schering’s business development strategy and the growing importance of Asia to the company.